Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Polaris International Equity's investment thesis on Jazz Pharmaceuticals plc ($JAZZ) — Q4 2025 | Buyside Digest

All Pitches

View Letter Analysis

$JAZZNASDAQJazz Pharmaceuticals plc

BULL

Polaris International Equity—JAZZ

Fund Letter

Q4 2025

Published December 31, 2025

View Fund Profile

$259.44USD

+5.1% vs last month

$173.15Pitched

+49.8% since pitch

Market Cap$16.8B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Polaris Capital Management's International Equity Composite delivered exceptional performance in 2025, posting a fourth-quarter return of 8.74% and a full-year return of 35.37% (net of fees). This significantly outpaced...

— Bernard Horn

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $JAZZ, and what else Polaris International Equity is buying.

Other pitches on $JAZZ

Other investors who've written on Jazz Pharmaceuticals plc

No other institutional pitches found for this ticker yet.

View all $JAZZ pitches →